Loo D T, Chalupny N J, Bajorath J, Shuford W W, Mittler R S, Aruffo A
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.
J Biol Chem. 1997 Mar 7;272(10):6448-56. doi: 10.1074/jbc.272.10.6448.
The T cell activation antigen 4-1BB (CDw137) is a distantly related member of the tumor necrosis factor receptor family of cell surface receptors. We previously reported that murine 4-1BB (m4-1BB) bound to extracellular matrix (ECM) proteins. Recently, a tumor necrosis factor-like ligand of m4-1BB, m4-1BBL, as well as the human counterparts of 4-1BB (ILA) and 4-1BBL (h4-1BB and h4-1BBL, respectively) have been cloned. No information is currently available on how binding of m4-1BB to ECM proteins affects its binding to m4-1BBL and vice versa and if the ability of m4-1BB to bind ECM proteins is conserved across species. We report that binding of m4-1BBL to m4-1BB blocked its ability to bind laminin (LN), while binding of m4-1BB to LN did not block its ability to bind m4-1BBL. Furthermore, binding of m4-1BBL to the m4-1BB.LN complex did not displace LN. These findings suggest the two ligands bind to proximal but distinct sites on m4-1BB. This is supported by the observation that six of eight anti-m4-1BB monoclonal antibodies blocked the interaction between 4-1BB and 4-1BBL, while seven blocked LN binding. Ligand and monoclonal antibody binding studies with a truncated protein lacking the amino-terminal LN-homologous domain of m4-1BB demonstrated that regions downstream of the LN-homologous domain participate in LN binding and that the intact protein is required for m4-1BBL binding. Studies with h4-1BB showed that h4-1BB only bound h4-1BBL, indicating that the ECM binding activity of 4-1BB is not conserved across species. This finding allowed the construction of murine/human 4-1BB chimeras, which permitted further dissection of the regions of 4-1BB involved in LN and 4-1BBL binding and suggests that sequence differences in the LN-homologous domain of h4-1BB in part account for the inability of h4-1BB to bind ECM proteins.
T细胞活化抗原4-1BB(CDw137)是细胞表面受体肿瘤坏死因子受体家族中关系较远的成员。我们之前报道过,小鼠4-1BB(m4-1BB)能与细胞外基质(ECM)蛋白结合。最近,m4-1BB的一种肿瘤坏死因子样配体m4-1BBL,以及4-1BB的人类对应物(ILA)和4-1BBL(分别为h4-1BB和h4-1BBL)已被克隆。目前尚无关于m4-1BB与ECM蛋白的结合如何影响其与m4-1BBL的结合,反之亦然,以及m4-1BB结合ECM蛋白的能力在物种间是否保守的信息。我们报道,m4-1BBL与m4-1BB的结合会阻断其与层粘连蛋白(LN)的结合能力,而m4-1BB与LN的结合并未阻断其与m4-1BBL的结合能力。此外,m4-1BBL与m4-1BB.LN复合物的结合并未取代LN。这些发现表明这两种配体结合在m4-1BB上相邻但不同的位点。这一观点得到了以下观察结果的支持:8种抗m4-1BB单克隆抗体中有6种阻断了4-1BB与4-1BBL之间的相互作用,而7种阻断了LN的结合。对缺失m4-1BB氨基末端LN同源结构域的截短蛋白进行的配体和单克隆抗体结合研究表明,LN同源结构域下游的区域参与LN的结合,而完整蛋白是m4-1BBL结合所必需的。对h4-1BB的研究表明,h4-1BB仅与h4-1BBL结合,这表明4-1BB的ECM结合活性在物种间并不保守。这一发现使得构建小鼠/人类4-1BB嵌合体成为可能,这有助于进一步剖析4-1BB中参与LN和4-1BBL结合的区域,并表明h4-1BB的LN同源结构域中的序列差异部分解释了h4-1BB无法结合ECM蛋白的原因。